Anemia Clinical Trial
Official title:
Effectiveness of Multiple Micro-nutrient Fortified Fudge on Nutritional Status of 3-5 Years of Age Children: A Randomize Control Trial
Verified date | February 2018 |
Source | University of Veterinary and Animal Sciences, Lahore - Pakistan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Multiple micro-nutrient deficiencies in Pakistan is wide spread, there is dire need to address these by using smart solutions, among them multiple fortified product (fudge) is an alternate possible way to address this issue. Fortified products have the potential to reduce micronutrient deficiencies in children, therefore in current study children from 3-5 years will receive fortified product along with enhance nutrition promotional information to bring change in their dietary practices and nutritional indices.
Status | Active, not recruiting |
Enrollment | 480 |
Est. completion date | August 30, 2018 |
Est. primary completion date | July 28, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 3 Years to 5 Years |
Eligibility |
Inclusion Criteria: - 3-5 years of age - no medical complication - from middle-income group within the semi-urban population Exclusion Criteria: - illness/ infections (TB, Malarial drug) - non-attendant - severe anemia/micro nutrient deficiency - thyroid disease - medication/supplementation - not willing to participate |
Country | Name | City | State |
---|---|---|---|
Pakistan | University of Veterinary and Animal Sciences | Lahore | Punjab |
Lead Sponsor | Collaborator |
---|---|
University of Veterinary and Animal Sciences, Lahore - Pakistan | PCSIR Laboratories Complex Karachi Pakistan, Sindh Lady Health Worker Program for Family Planning and Primary Health Care |
Pakistan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To access the improvement in child Iron deficiency anemia | change in serum Hemoglobin, serum ferritin and serum transferrin receptors | Will be accessed at Base-line (at start), Mid-line (after 4 months) and End-line (8 months) | |
Primary | To access the improvement in children Vitamin A status | Change in Serum retinol binding protein | Will be accessed at Base-line (at start), Mid-line (after 4 months) and End-line (8 months) | |
Primary | To access the improvement in children Zinc status | Change in serum zinc | Will be accessed at Base-line (at start), Mid-line (after 4 months) and End-line (8 months) | |
Secondary | Difference in the children anthropocentric status | Mean z-scores (weight-for-age, length-for-age z-scores, weight-for-length) based on the WHO child growth standards 2006 | Base-line (at start, 0 month), Mid-line (after 4 months) and End-line (8 months at start) | |
Secondary | Effect on the household food security | Diet diversity score based on dietary intake and preferences by 24 hrs dietary recall and Household Food Security Scale | Base-line (at start, 0 month), Mid-line (after 4 months) and End-line (8 months at start) | |
Secondary | Enhancement in the early childhood development indicators | Gain change in the cognitive, motor and socio-emotional assessment through questionnaire filled by caretaker | Base-line (at start, 0 month), Mid-line (after 4 months) and End-line (8 months at start) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Terminated |
NCT01535781 -
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
|
N/A | |
Completed |
NCT01458028 -
Age and Gender Effects on the Pharmacokinetics of BAY85-3934
|
Phase 1 |